KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to 21.49%.

  • Medpace Holdings' EBIT Margin rose 4400.0% to 21.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.5%, marking a year-over-year increase of 17600.0%. This contributed to the annual value of 21.19% for FY2024, which is 33300.0% up from last year.
  • Latest data reveals that Medpace Holdings reported EBIT Margin of 21.49% as of Q3 2025, which was up 4400.0% from 20.94% recorded in Q2 2025.
  • Medpace Holdings' EBIT Margin's 5-year high stood at 23.37% during Q4 2024, with a 5-year trough of 15.25% in Q2 2021.
  • In the last 5 years, Medpace Holdings' EBIT Margin had a median value of 19.4% in 2022 and averaged 19.2%.
  • In the last 5 years, Medpace Holdings' EBIT Margin tumbled by -34000bps in 2021 and then soared by 58500bps in 2024.
  • Over the past 5 years, Medpace Holdings' EBIT Margin (Quarter) stood at 17.78% in 2021, then increased by 9bps to 19.39% in 2022, then fell by -10bps to 17.52% in 2023, then surged by 33bps to 23.37% in 2024, then dropped by -8bps to 21.49% in 2025.
  • Its last three reported values are 21.49% in Q3 2025, 20.94% for Q2 2025, and 20.32% during Q1 2025.